Aberrant, highly hyperdiploid cells in human papillomavirus-positive, abnormal cytologic samples are associated with progressive lesions of the uterine cervix

Cancer

Volumn 105, Issue 2, 2005, Pages 96-100

  Bollmann, Reinhard ^a   Méhes, Gábor ^b   Speich, Norbert ^c   Schmitt, Christoph ^c   Bollmann, Magdolna ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Inst of Molec Pathol/Gene Diagn   (Germany)

Author keywords

Aneuploidy; Bethesda classification; Carcinoma; Cervical dysplasia; DNA cytometry; Human papillomavirus; Progression

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER GRADING; CELL NUCLEUS; CELL STRUCTURE; CYTODIAGNOSIS; CYTOMETRY; DIAGNOSTIC ACCURACY; DIPLOIDY; DNA CONTENT; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; NONHUMAN; OUTCOMES RESEARCH; PAPILLOMA VIRUS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VERRUCA VULGARIS; VIRUS ONCOGENE;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; DNA; FEMALE; FOLLOW-UP STUDIES; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYPLOIDY; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 18044387967     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20848     Document Type: Article

References (16)

1. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
2. Zur Hausen H. Cervical carcinoma and human papillomavirus: on the road to preventing a major cancer. J Natl Cancer Inst. 2001;93:252-253.
3. [No authors listed.] The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Acta Cytol. 1989;33:567-572.
4. [No authors listed.] The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. Acta Cytol. 1992;36:273-276.
5. Booking A, Hilgarth M, Auffermann W, Hack-Werdier C, Fischer-Becker D, von Kalkreuth D. DNA cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix. Acta Cytol. 1986;39:608-615.
6. Steinbeck RG. Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis. Acta Oncol. 1997;36:3-12.
7. Bollmann R, Bollmann M, Henson DE, Bodo M. DNA-cytometry confirms the utility of the Bethesda System for the classification of Papanicolaou smears. Cancer (Cancer Cytopathol). 2001;93:222-228.
8. Booking A, Nguyen VQ. Diagnostic and prognostic use of DNA image cytometry in cervical squamous intraepithelial lesions and invasive carcinoma. Cancer (Cancer Cytopathol). 2004;102:41-54.
9. Bollmann R, Méhes G, Torka R, Speich N, Schmitt C, Bollmann M. Human papillomavirus typing and DNA ploidy determination of squamous intraepithelial lesions in liquid based cytologic samples. Cancer (Cancer Cytopathol). 2003;99):57-62.
10. Bollmann R, Méhes G, Torka R, Speich N, Schmitt C, Bollmann M. Determination of features indicating progression in atypical squamous cells with undetermined significance. HPV-typing and DNA-ploidy analysis from liquid based cytological samples. Cancer (Cancer Cytopathol). 2003;99:113-117.
11. Speich N, Schmitt C, Bollmann R, Bollmann M. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol. 2004;53:1-4.
12. Feoli-Fonseca JC, Oligny LL, Filion M, et al. A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Mol Pathol. 1998;7:317-323.
13. Jacobs MV, Snijders PJ, van den Brule JC, Heimerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5 + /GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997;35:791-795.
14. Bauer HM, Greer CE, Manos MM. Determination of genital HPV infection using consensus PCR. In: Herrington CS, McGee JO, editors. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press, 1992:131-152.
15. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
16. Méhes G, Speich N, Bollmann M, Bollmann R. Chromosomal aberrations accumulate in polyploid cells of cervical squamous intraepithelial lesions (HSIL). Pathol Oncol Res. 2004;10:142-148.